Ferrer Internacional Company Profile
✉ Email this page to a colleague
What is the competitive landscape for FERRER INTERNACIONAL, and what generic alternatives to FERRER INTERNACIONAL drugs are available?
FERRER INTERNACIONAL has one approved drug.
There are two US patents protecting FERRER INTERNACIONAL drugs.
There are thirty-three patent family members on FERRER INTERNACIONAL drugs in twenty-three countries and seven supplementary protection certificates in seven countries.
Summary for Ferrer Internacional
International Patents: | 33 |
US Patents: | 2 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Drugs and US Patents for Ferrer Internacional
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ferrer Internacional | XEPI | ozenoxacin | CREAM;TOPICAL | 208945-001 | Dec 11, 2017 | RX | Yes | Yes | 9,399,014 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ferrer Internacional | XEPI | ozenoxacin | CREAM;TOPICAL | 208945-001 | Dec 11, 2017 | RX | Yes | Yes | 9,180,200 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Ferrer Internacional
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ferrer Internacional | XEPI | ozenoxacin | CREAM;TOPICAL | 208945-001 | Dec 11, 2017 | 6,335,447 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Ferrer Internacional Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Mexico | 338029 | ⤷ Try a Trial |
Japan | 5873120 | ⤷ Try a Trial |
Chile | 2011000848 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Ferrer Internacional Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2344130 | 300884 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: OZENOXACIN; REGISTRATION NO/DATE: ES/H/414/1/DC 20170519 |
2344130 | 2017/038 | Ireland | ⤷ Try a Trial | PRODUCT NAME: OZENOXACIN; NAT REGISTRATION NO/DATE: PA1744/003/001 20170616; FIRST REGISTRATION NO/DATE: ES/H/414/01/DC 20170519 |
2344130 | 1790031-7 | Sweden | ⤷ Try a Trial | PRODUCT NAME: OZENOXACIN; NAT. REG. NO/DATE: 54608 20170622; FIRST REG.: BE ES/H/414/01/DC 20170519 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.